Selective primer unblocking of carbovir, lamivudine, tenofovir and zidovudine by wild-type HIV reverse transcriptase with nucleotide and deoxynucleotide triphosphates

被引：0
|
作者：
Gerondelis, P [1 ]
Underwood, MR [1 ]
Lanier, ER [1 ]
机构：
[1] GlaxoSmithKline Inc, Dept Int Clin Virol, Res Triangle Pk, NC USA
来源：
ANTIVIRAL THERAPY | 2004年 / 9卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：U37 / U38
页数：2
相关论文
共 50 条
  • [21] Development of Hexadecyloxypropyl Tenofovir (CMX157) for Treatment of Infection Caused by Wild-Type and Nucleoside/Nucleotide-Resistant HIV
    Lanier, E. Randall
    Ptak, Roger G.
    Lampert, Bernhard M.
    Keilholz, Laurie
    Hartman, Tracy
    Buckheit, Robert W., Jr.
    Mankowski, Marie K.
    Osterling, Mark C.
    Almond, Merrick R.
    Painter, George R.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (07) : 2901 - 2909
  • [22] A theoretical study of the inhibition of wild-type and drug-resistant HIV-1 reverse transcriptase by some thiazolidenebenzenesulfonamide derivatives
    Soto-Morales, Francisco
    Gomez-Jeria, Juan S.
    JOURNAL OF THE CHILEAN CHEMICAL SOCIETY, 2007, 52 (03): : 1214 - 1219
  • [23] Effect of a bound non-nucleoside RT inhibitor on the dynamics of wild-type and mutant HIV-1 reverse transcriptase
    Zhou, ZG
    Madrid, M
    Evanseck, JD
    Madura, JD
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2005, 127 (49) : 17253 - 17260
  • [24] Ninety-six-week efficacy of combination therapy with lamivudine and tenofovir in patients coinfected with HIV-1 and wild-type hepatitis B virus
    Bani-Sadr, F
    Palmer, P
    Scieux, C
    Molina, JM
    CLINICAL INFECTIOUS DISEASES, 2004, 39 (07) : 1062 - 1064
  • [25] Evaluation of mixtures of wild-type HlV-1 and HIV-1 with resistance point mutations against reverse transcriptase inhibitors
    Villahermosa, ML
    Contreras, G
    Pérez-Alvarez, L
    Bru, F
    Medrano, L
    Delgado, E
    Colomo, C
    Thomson, M
    Nájera, R
    ANTIVIRAL THERAPY, 1998, 3 (04) : 221 - 228
  • [26] The M184V mutation in HIV-1 reverse transcriptase reduces the restoration of wild-type replication by attenuated viruses
    Wei, X
    Liang, C
    Götte, M
    Wainberg, MA
    AIDS, 2002, 16 (18) : 2391 - 2398
  • [27] Structure-based drug design of non-nucleoside inhibitors for wild-type and drug-resistant: HIV reverse transcriptase
    Mao, C
    Sudbeck, EA
    Venkatachalam, TK
    Uckun, FM
    BIOCHEMICAL PHARMACOLOGY, 2000, 60 (09) : 1251 - 1265
  • [28] Resolution of Specific Nucleotide Mismatches by Wild-Type and AZT-Resistant Reverse Transcriptases during HIV-1 Replication
    Kharytonchyk, Siarhei
    King, Steven R.
    Ndongmo, Clement B.
    Stilger, Krista L.
    An, Wenfeng
    Telesnitsky, Alice
    JOURNAL OF MOLECULAR BIOLOGY, 2016, 428 (11) : 2275 - 2288
  • [29] Benzophenone derivatives of pyrimidines as effective non-nucleoside inhibitors of wild-type and drug-resistant HIV-1 reverse transcriptase
    Prokofjeva, M. M.
    Valuev-Elliston, V. T.
    Ivanov, A. V.
    Kochetkov, S. N.
    Novikov, M. S.
    Prassolov, V. S.
    DOKLADY BIOCHEMISTRY AND BIOPHYSICS, 2012, 447 (01) : 280 - 281
  • [30] Benzophenone derivatives of pyrimidines as effective non-nucleoside inhibitors of wild-type and drug-resistant HIV-1 reverse transcriptase
    M. M. Prokofjeva
    V. T. Valuev-Elliston
    A. V. Ivanov
    S. N. Kochetkov
    M. S. Novikov
    V. S. Prassolov
    Doklady Biochemistry and Biophysics, 2012, 447 : 280 - 281
12345